糖尿病保健公司Tandem Diabetes Care Inc（TNDM）今日盘后股价大涨6.17%，引起市场广泛关注。尽管公司公布的季度业绩显示亏损超出预期，但强劲的营收增长似乎获得了投资者的青睐。
根据公司发布的最新财报，截至3月31日的季度调整后每股亏损为0.66美元，略高于分析师平均预期的0.61美元亏损。然而，公司营收同比大幅增长21.6%，达到2.3442亿美元，超过了分析师预期的2.2020亿美元。这一营收表现可能是推动股价上涨的主要因素。
值得注意的是，Tandem公司股价今年以来已下跌53.4%，显示出投资者此前对公司前景的担忧。此次财报虽然亏损幅度扩大，但营收的强劲增长可能暗示公司业务正在改善，这或许重新点燃了投资者的信心。分析师对该公司的平均评级仍为"买入"，未来12个月目标价中位数为36.00美元，这也可能支撑了投资者的乐观情绪。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.